The Imbalance of B-Lymphocyte Subsets in Subjects with Different Glucose Tolerance: Relationship with Metabolic Parameter and Disease Status

Table 1

Anthropometric and metabolic data of subjects according to glucose tolerance.

	NGT ()	IGR ()	T2D ()
Male (%)	40.2 (68/169)	38.4 (28/73)	46.7 (28/60)
Age (y)	46.38 ± 11.07	49.86 ± 11.07	47.75 ± 13.52
BMI (kg/m^2)	23.79 ± 3.31	24.26 ± 2.92	24.33 ± 3.36
WC (cm)	82.23 ± 10.52	84.93 ± 9.01	85.48 ± 8.18
WHR	0.85 ± 0.06	0.87 ± 0.06	0.88 ± 0.05
SBP (mmHg)	116.09 ± 15.07	122.59 ± 16.90	128.50 ± 16.30
DBP (mmHg)	75.68 ± 11.12	78.80 ± 11.93	84.15 ± 9.37
TG (mmol/L)^§	1.16 (0.78–1.78)	1.49 (1.08–2.06)	2.03 (0.89–2.97)
TC (mmol/L)	5.09 ± 0.96	5.03 ± 0.95	5.12 ± 1.16
LDL-C (mmol/L)	2.85 ± 0.86	3.12 ± 0.80	3.06 ± 0.82
HDL-C (mmol/L)	1.36 (1.11–1.59)	1.26 (1.09–1.46)	1.09 (0.80–1.31)^†
HbA1c (%)	NA	NA	6.70 (5.60–8.50)
HbA1c (mmol/L)	NA	NA	50 (38–69)
FPG (mmol/L)^¶	5.20 (4.80–5.50)	5.70 (5.20–6.20)	7.19 (5.71–8.79)^†††
FCP (mmol/L)^¶	0.45 (0.34–0.63)	0.55 (0.45–0.73)	0.64 (0.37–0.79)

Data are % (), mean ± SD, and median (25th–75th percentile). ^§Compared after Log transformation. ^¶Compared by the nonparametric Kruskal-Wallis test; IGR: impaired glucose regulation subjects; N/A: not appropriate; NGT: normal glucose tolerance subjects; T2D: type 2 diabetic subjects; BMI: body mass index; DBP: diastolic blood pressure; FCP: fasting C-peptide; FPG: fasting plasma glucose; HbA1c: glycated hemoglobin; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TC: total cholesterol; TG: triglycerides; SBP: systolic blood pressure; WC: waist circumference; WHR: waist-hip ratio; compared with that in the NGT, compared with that in the NGT, compared with that in the NGT, ^† compared with that in the IGR, and ^††† compared with that in the IGR.